$NKTX
Nkarta Inc

2023 Q4 Form 10-Q Financial Statement

#000095017023062091 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.863M $7.100M
YoY Change -3.39% 4.0%
% of Gross Profit
Research & Development $23.32M $22.19M
YoY Change -13.12% -5.3%
% of Gross Profit
Depreciation & Amortization $2.251M $2.000M
YoY Change 208.78% 185.71%
% of Gross Profit
Operating Expenses $31.19M $29.29M
YoY Change -10.86% -3.2%
Operating Profit -$29.29M
YoY Change -3.2%
Interest Expense $3.456M $3.620M
YoY Change 19.58% 90.53%
% of Operating Profit
Other Income/Expense, Net -$25.00K $3.649M
YoY Change -94.89% 90.35%
Pretax Income -$27.75M -$25.65M
YoY Change -14.82% -9.51%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$27.75M -$25.65M
YoY Change -14.82% -9.53%
Net Earnings / Revenue
Basic Earnings Per Share -$0.52
Diluted Earnings Per Share -$0.57 -$0.52
COMMON SHARES
Basic Shares Outstanding 49.07M 49.06M
Diluted Shares Outstanding 49.06M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $248.2M $275.6M
YoY Change -29.52% -29.76%
Cash & Equivalents $31.04M $38.26M
Short-Term Investments $217.1M $237.4M
Other Short-Term Assets $4.882M $1.589M
YoY Change 66.68% -53.71%
Inventory
Prepaid Expenses $3.263M $3.986M
Receivables
Other Receivables
Total Short-Term Assets $253.1M $281.2M
YoY Change -29.84% -29.86%
LONG-TERM ASSETS
Property, Plant & Equipment $119.3M $77.69M
YoY Change 92.66% 156.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.539M $3.727M
YoY Change 253.46% 94.22%
Total Long-Term Assets $125.8M $124.7M
YoY Change 12.08% 21.18%
TOTAL ASSETS
Total Short-Term Assets $253.1M $281.2M
Total Long-Term Assets $125.8M $124.7M
Total Assets $378.9M $405.9M
YoY Change -19.89% -19.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.665M $4.284M
YoY Change 108.12% -54.88%
Accrued Expenses $18.81M $15.30M
YoY Change 17.3% 32.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.33M $25.64M
YoY Change 5.82% -2.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $82.27M $83.40M
YoY Change 4.56% 1667900.0%
Total Long-Term Liabilities $82.27M $83.40M
YoY Change 4.56% 1667900.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.33M $25.64M
Total Long-Term Liabilities $82.27M $83.40M
Total Liabilities $105.6M $109.0M
YoY Change 4.83% 4.32%
SHAREHOLDERS EQUITY
Retained Earnings -$435.4M -$407.7M
YoY Change 36.96% 42.85%
Common Stock $708.7M $704.9M
YoY Change 2.59% 2.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $273.3M $296.8M
YoY Change
Total Liabilities & Shareholders Equity $378.9M $405.9M
YoY Change -19.89% -19.44%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$27.75M -$25.65M
YoY Change -14.82% -9.53%
Depreciation, Depletion And Amortization $2.251M $2.000M
YoY Change 208.78% 185.71%
Cash From Operating Activities -$23.35M -$20.28M
YoY Change 218.56% 37.05%
INVESTING ACTIVITIES
Capital Expenditures $6.807M $6.190M
YoY Change -80.57% -180.66%
Acquisitions
YoY Change
Other Investing Activities $22.64M $35.61M
YoY Change -43.08% -149.85%
Cash From Investing Activities $15.84M $29.42M
YoY Change 233.62% -137.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 295.0K 0.000
YoY Change -30.42% -100.0%
NET CHANGE
Cash From Operating Activities -23.35M -20.28M
Cash From Investing Activities 15.84M 29.42M
Cash From Financing Activities 295.0K 0.000
Net Change In Cash -7.222M 9.140M
YoY Change 234.35% -110.01%
FREE CASH FLOW
Cash From Operating Activities -$23.35M -$20.28M
Capital Expenditures $6.807M $6.190M
Free Cash Flow -$30.16M -$26.47M
YoY Change -28.81% 271.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001787400
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39370
dei Entity Registrant Name
EntityRegistrantName
Nkarta, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4515206
dei Entity Address Address Line1
EntityAddressAddressLine1
1150 Veterans Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
925
dei Local Phone Number
LocalPhoneNumber
407-1049
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
NKTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49072342
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38262000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37494000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
237351000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
314649000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5575000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8545000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
281188000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
360688000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2743000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2743000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77687000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61908000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40519000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
45749000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3727000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1850000
CY2023Q3 us-gaap Assets
Assets
405864000
CY2022Q4 us-gaap Assets
Assets
472938000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4284000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1761000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6057000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4249000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15299000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16036000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25640000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22046000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
83408000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78685000
CY2023Q3 us-gaap Liabilities
Liabilities
109048000
CY2022Q4 us-gaap Liabilities
Liabilities
100731000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
704900000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
690814000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-409000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-679000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-407680000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-317933000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
296816000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
372207000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
405864000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
472938000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22194000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23435000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73451000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64053000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7100000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6827000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27014000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19919000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
29294000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
30262000
us-gaap Operating Expenses
OperatingExpenses
100465000
us-gaap Operating Expenses
OperatingExpenses
83972000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-29294000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30262000
us-gaap Operating Income Loss
OperatingIncomeLoss
-100465000
us-gaap Operating Income Loss
OperatingIncomeLoss
-83972000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
3616000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1900000
us-gaap Investment Income Net
InvestmentIncomeNet
10651000
us-gaap Investment Income Net
InvestmentIncomeNet
2698000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
67000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3649000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1917000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10718000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2717000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-25645000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-28345000
us-gaap Net Income Loss
NetIncomeLoss
-89747000
us-gaap Net Income Loss
NetIncomeLoss
-81255000
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
192000
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-390000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
270000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1171000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25453000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28735000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89477000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-82426000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.94
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49062799
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49062799
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48630328
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48630328
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48985373
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48985373
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41878716
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41878716
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
372207000
CY2023Q1 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
2000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4746000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
505000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-30815000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
346646000
CY2023Q2 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
1000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
374000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4650000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-427000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-33287000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
317978000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4291000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
192000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-25645000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
296816000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
250967000
CY2022Q1 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
6000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
79000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4097000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-456000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25987000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
228706000
CY2022Q2 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
3000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
334000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3912000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-325000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26923000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
421041000
CY2022Q3 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
3000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
953000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4390000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-390000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-28345000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
399264000
us-gaap Profit Loss
ProfitLoss
-89747000
us-gaap Profit Loss
ProfitLoss
-81255000
us-gaap Share Based Compensation
ShareBasedCompensation
13687000
us-gaap Share Based Compensation
ShareBasedCompensation
12399000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3618000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1908000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6915000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-763000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
34000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
4100000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1653000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3269000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1093000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1575000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
6112000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
11446000
nktx Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
3627000
nktx Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
3376000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62806000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49669000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21340000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12073000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
196877000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
310313000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
281395000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
132950000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
63178000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-189436000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1365000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
374000
nktx Proceeds From At The Market Offering Net Of Issuance Costs
ProceedsFromAtTheMarketOfferingNetOfIssuanceCosts
1612000
nktx Proceeds From Secondary Offering Net Of Issuance Costs
ProceedsFromSecondaryOfferingNetOfIssuanceCosts
215611000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
396000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218588000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
768000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20517000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40237000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62914000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41005000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42397000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38262000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39654000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
2743000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
2743000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41005000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42397000
nktx Noncash Or Part Noncash Acquisition Fixed Assets Acquired Included In Accounts Payable And Accrued And Other Current Liabilities
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredIncludedInAccountsPayableAndAccruedAndOtherCurrentLiabilities
1842000
nktx Noncash Or Part Noncash Acquisition Fixed Assets Acquired Included In Accounts Payable And Accrued And Other Current Liabilities
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredIncludedInAccountsPayableAndAccruedAndOtherCurrentLiabilities
7228000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-407700000
CY2023Q3 nktx Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
278400000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to preclinical studies, percentage of completion of manufacturing activities, fair value of assets and liabilities, impairment of assets, leases, share-based compensation and income taxes. Management bases its estimates on historical experience, knowledge of current events and actions it may undertake in the future that management believes to be reasonable under the circumstances. Actual results may differ from these estimates and assumptions.</span></p>
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-25645000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-28345000
us-gaap Net Income Loss
NetIncomeLoss
-89747000
us-gaap Net Income Loss
NetIncomeLoss
-81255000
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
49062799
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
48631941
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
48985448
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
41882929
CY2022Q3 nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-1613
nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-75
nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-4213
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49062799
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49062799
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48630328
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48630328
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48985373
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48985373
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41878716
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41878716
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.94
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7822559
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5672894
CY2023Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
17437000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
237351000
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
254788000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
36494000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
314649000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
351143000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
237760000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
411000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
237351000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
315328000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
762000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
83000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
314649000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3986000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5616000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1589000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2929000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5575000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8545000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
7800000
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
6600000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
9500000
us-gaap Payments For Rent
PaymentsForRent
2900000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87129000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67732000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9442000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5824000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77687000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61908000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2000000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3600000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
700000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6021000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6691000
CY2023Q3 nktx Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
6042000
CY2022Q4 nktx Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3486000
CY2023Q3 nktx Accrued Property And Equipment Liabilities Current
AccruedPropertyAndEquipmentLiabilitiesCurrent
2190000
CY2022Q4 nktx Accrued Property And Equipment Liabilities Current
AccruedPropertyAndEquipmentLiabilitiesCurrent
5001000
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1046000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
858000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15299000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16036000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
8200000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
8200000
us-gaap Operating Lease Payments
OperatingLeasePayments
500000
us-gaap Payments For Rent
PaymentsForRent
8300000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.098
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12Y
CY2021Q3 nktx Cash Received For Tenant Improvement Allowances To Be Repaid
CashReceivedForTenantImprovementAllowancesToBeRepaid
4400000
CY2023Q2 nktx Cash Received For Tenant Improvement Allowances To Be Repaid
CashReceivedForTenantImprovementAllowancesToBeRepaid
4400000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3364000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12720000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13027000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13462000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13912000
CY2023Q3 nktx Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
87254000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
143739000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
54274000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
89465000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6057000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
83408000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
89465000
CY2023Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
4100000
CY2023Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2023Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2022Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
nktx Contingency Loss Recorded
ContingencyLossRecorded
0
nktx Provision For Loss Contingency
ProvisionForLossContingency
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.35
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4291000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4390000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13687000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12399000
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
26400000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-062091-index-headers.html Edgar Link pending
0000950170-23-062091-index.html Edgar Link pending
0000950170-23-062091.txt Edgar Link pending
0000950170-23-062091-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nktx-20230930.htm Edgar Link pending
nktx-20230930.xsd Edgar Link pending
nktx-ex31_1.htm Edgar Link pending
nktx-ex31_2.htm Edgar Link pending
nktx-ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
nktx-20230930_lab.xml Edgar Link unprocessable
nktx-20230930_pre.xml Edgar Link unprocessable
nktx-20230930_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nktx-20230930_cal.xml Edgar Link unprocessable
nktx-20230930_def.xml Edgar Link unprocessable